BAD and breast carcinoma: In our study, immunohistochemistry was used to detect the expression of BCL-2 and BAD in breast carcinoma, in addition, to analyze the relationship between the expression of the two genes and the expression of ER, PR histologic grade, clinical stage and the lymph node metastasis.